[Pustular dermatitis after administration of a too highly concentrated dithranol ointment in seborrhea].
Seborrhoic dermatitis is an erythematosquamous condition of unknown etiology with a prevalence of approximately 2.5%. Frequently difficult to treat, it may respond to the application of low doses of dithranol, a substance which can induce a pustular dermatitis as an adverse side effect depending on the applied concentration and individual susceptibility. We describe a pustular dermatitis after the application of a preparation containing dithranol at an erroneously high concentration in a 30-year-old patient with seborrhoic dermatitis.
Ludolph-Hauser
D
D
Dermatologische Klinik und Poliklinik der Ludwig-Maximilians-Universität München.
Michelsen
S
S
Korting
H C
HC
D000287:Administration, Topical; D000328:Adult; D000875:Anthralin / Q000008:administration & dosage / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D012628:Dermatitis, Seborrheic / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D003875:Drug Eruptions / Q000209:etiology*; D005148:Facial Dermatoses / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008508:Medication Errors; D009824:Ointments
D000893:Anti-Inflammatory Agents; D009824:Ointments; D000875:Anthralin
Pustulöse Dermatitis nach Anwendung einer zu hoch konzentrierten magistralen Dithranolzubereitung bei seborrhoischem Ekzem.